| Today, Mon, Nov 9, 2009 | | | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon 4:31pm)
| | Tue, Nov 3, 2009 | | | Nice Quarter, Teva. What Will You Buy Next? at Motley Fool (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | | UPDATE - Deals of the day -- mergers and acquisitions at Reuters (Mon, Nov 2)
| | | Pfizer eyes deal with Israel's Protalix-newspaper at Reuters (Mon, Nov 2)
| | Thu, Oct 29, 2009 | | | Protalix BioTherapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference Business Wire (Thu, Oct 29)
| | Mon, Oct 26, 2009 | | | Biotech Stocks: Pharma stocks turn lower; BioCryst, Vivus gain at MarketWatch (Mon, Oct 26)
| | | Biotech Stocks: Drug stocks edge up; BioCryst soars on flu news at MarketWatch (Mon, Oct 26)
| | Thu, Oct 22, 2009 | | | The Gift That Keeps on Giving at Motley Fool (Thu, Oct 22)
| | Wed, Oct 21, 2009 | | | Genzyme Misses & Slashes Zacks.com (Wed, Oct 21)
| | Thu, Oct 15, 2009 | | | Protalix says Gaucher drug met goals in trial AP (Thu, Oct 15)
| | | UPDATE - Protalix drug success puts new pressure on Genzyme at Reuters (Thu, Oct 15)
| | | CORRECTING and REPLACING Protalix BioTherapeutics Announces Positive Top-line Results from its Phase III Clinical Trial of UPLYSO for the Treatment of Gaucher Disease Business Wire (Thu, Oct 15)
| | | Protalix reports positive Phase III trial results at MarketWatch (Thu, Oct 15)
| | | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online (Thu, Oct 15)
| | Wed, Oct 14, 2009 | | | [$$] Production Snafus Expose Genzyme to Rivals at The Wall Street Journal Online (Wed, Oct 14)
| | Thu, Sep 24, 2009 | | | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online (Thu, Sep 24)
| | | Genzyme Struggles to Restore Order Zacks.com (Thu, Sep 24)
| | | Sell Genzyme Near Term Due to Challenges with Manufacturing Biologics at Seeking Alpha (Thu, Sep 24)
| | Tue, Sep 22, 2009 | | | Coverage initiated on Protalix BioTherapeutics by Canaccord Adams Briefing.com (Tue, Sep 22)
| | | Protalix Reports Preclinical Data on Anti-TNF Follow-on Biologic Arthritis Drug Business Wire (Tue, Sep 22)
| Add PLX News to My Yahoo!:

| |
|